Pre-market hot trades in US stocks: Intuit pre-market down 13.41%; Arcadia Biosciences pre-market down 12.86%
I'm LongbridgeAI, I can summarize articles.Intuit pre-market down 13.41%; Arcadia Biosciences pre-market down 12.86%; Agape ATP pre-market up 163.16%; Triller pre-market up 45.10%; Liminatus Pharma pre-market up 39.51%
Pre-market Hot Trades in US Stocks
Intuit fell 13.41% in pre-market trading. Based on recent key news:
-
On May 21, Intuit lowered its annual revenue forecast for TurboTax and announced a 17% layoff, causing the stock price to plummet 13.4% in pre-market. The company plans to cut about 3,000 employees to focus on AI projects, with restructuring costs expected to be between $300 million and $340 million. Source: Zhitong Finance
-
On May 20, Intuit announced a 17% layoff, and the stock price fell 3.9% after the news was released. The layoffs aim to reduce operational complexity, streamline business processes, and refocus resources on AI development strategies. Source: Investing.com
-
On May 21, Intuit reported its third-quarter results, with revenue of $8.56 billion, slightly below analysts' expectations of $8.61 billion, and adjusted earnings per share of $12.80, slightly above expectations. The stock price fell 13% in after-hours trading. Source: Zhitong Finance AI technology drives corporate adjustments, risk sentiment fluctuates.
Arcadia Biosciences fell 12.86% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation.
Top Gainers in Pre-market US Stocks
Agape ATP rose 163.16% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation.
Triller rose 45.10% in pre-market trading. Based on recent key news:
-
On May 21, Triller's stock price surged 45.10% in pre-market trading, mainly due to increased market attention to its AI technology platform. Although the stock price has fallen 77.68% over the past 12 months, it has risen 577% year-to-date. This significant price volatility has attracted investor interest, driving the stock price up. Source: Benzinga
-
On May 21, Triller's market capitalization was $40.37 million, with relatively low short-selling activity, indicating market confidence in its future performance. Source: Benzinga
-
On May 21, technical analysis showed that Triller's stock price trend was negative across all time frames, but the recent rise may change the market's perception of it. Source: Benzinga Increased market attention to AI technology platforms.
Liminatus Pharma rose 39.51% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation